Showing results (241-250 of 268) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancerK T Robbins, A M Storniolo, C Kerber, et al.
American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.
Cancer|March 1, 1997
A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaE F McClay, M E McClay, J A Jones, et al.
Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.
British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.
Cancer|September 15, 1993
Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observationE F Mc Clay, M E Mc Clay, K D Albright, et al.
The Journal of Clinical Investigation|October 1, 1992
Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alphaS Isonishi, A P Jekunen, D K Hom, et al.
Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancerM Andersson, K F Aronsen, C Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancerS B Howell, S Kirmani, W E Lucas, et al.
Pageof 27